心不全におけるベータ2アドレネルゲン受容体の再分布は,cAMPの分割を変化させます
Viacheslav O Nikolaev1, Alexey Moshkov, Alexander R Lyon
1Department of Cardiac Medicine, National Heart and Lung Institute, Imperial College London, Dovehouse Street, London SW3 6LY, UK.
Science (New York, N.Y.)
|February 27, 2010
まとめ
心臓細胞のベータアドレナリン受容体 (β-ARs) は,心臓の機能を制御する. 心不全では,β2ARが移動し,循環性アデノシンモノフォスファート (cAMP) 信号を変化させ,潜在的に状態を悪化させます.
科学分野:
- 心臓病学 心臓病学
- 分子細胞生物学 分子細胞生物学
- バイオフィジックス 生物物理学
背景:
- ベータ1およびベータ2アドレナリン受容体 (ベータAR) は,循環性アデノシンモノフォスファート (cAMP) 経由で心筋細胞機能と心不全の発達を調節する.
- 心筋細胞内のベータARの正確な空間的位置と機能的意義は,ほとんど未定のままである.
- ベータARは,ヘテロトリメリックグアニン核酸結合タンパク質 (Gタンパク質) と結合している.
研究 の 目的:
- 心筋細胞におけるβ1およびβ2アドレナリン受容体 (βARs) の空間的分布を調査する.
- 周期性アデノシンモノフォスファート (cAMP) 信号伝達に対するβAR局在化の機能的影響を明らかにする.
- 慢性心不全モデルにおけるβAR局所化とcAMPシグナル伝達における変化を調べる.
主な方法:
- ナノスケール活細胞スキャニングイオン伝導性顕微鏡を用いた.
- 光共振エネルギー伝送 (FRET) 顕微鏡を用いた.
- 健康な成人のラットとマウスの心筋細胞と,慢性心不全のラットモデルを研究した.
主要な成果:
- 健康な心筋細胞では,β2AR誘発のcAMP信号は深い横管に限られ,β1ARは広く分布していた.
- 心不全モデル心筋細胞では,β2ARが横管から細胞頂上へと再分布した.
- この再分布は,局所的ではなく,分散した受容体媒介のcAMPシグナル伝達をもたらした.
結論:
- ベータARの空間的局所化は,心筋細胞における区画化されたcAMPシグナル伝達に不可欠である.
- 心不全におけるβ2ARの再分配は,cAMPの分割を変化させる.
- 変異したβ2ARの局所化とcAMPのシグナル伝達が,心筋機能不全のフェノタイプに寄与する可能性があります.
関連する概念動画
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:26Adrenergic Receptors: β Subtype
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
01:22Heart Failure Drugs: β-Blockers
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:26Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...